These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 28948727)
1. [Advances in animal model and traditional Chinese medicine prevention in coronary microvascular dysfunction]. Li L; Liu JX; Ren JX; Guo H; Lin CR Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(2):254-258. PubMed ID: 28948727 [TBL] [Abstract][Full Text] [Related]
2. Metabolomics and its application in the treatment of coronary heart disease with traditional Chinese medicine. Wu GS; Li HK; Zhang WD Chin J Nat Med; 2019 May; 17(5):321-330. PubMed ID: 31171266 [TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery. Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315 [TBL] [Abstract][Full Text] [Related]
4. Research status of pathogenesis of anxiety or depression after percutaneous coronary intervention and Traditional Chinese Medicine intervention. Ning B; Ge T; Zhao QQ; Feng LS; Wu YQ; Chen H; Lian K; Zhao MJ J Ethnopharmacol; 2024 Jun; 327():118017. PubMed ID: 38462028 [TBL] [Abstract][Full Text] [Related]
5. [Theoretical thinking on guiding research and development of new drugs of traditional Chinese medicine]. Yang ZQ; Tang HM; Tang YQ; DU YP; Yuan WA; Li B; Zou C; Tang JY; Gao R; Hu SY; Zhang L Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1686-1690. PubMed ID: 33982469 [TBL] [Abstract][Full Text] [Related]
6. [Recent advances on pericytes in microvascular dysfunction and traditional Chinese medicine prevention]. Liu L; Liu JX; Guo H; Ren JX Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3072-3077. PubMed ID: 29171223 [TBL] [Abstract][Full Text] [Related]
7. [Therapy for replenishing qi, nourishing yin and promoting blood circulation in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial]. Qiu SL; Jin M; Yi JH; Zhu TG; Quan X; Liang Y Zhong Xi Yi Jie He Xue Bao; 2009 Jul; 7(7):616-21. PubMed ID: 19615314 [TBL] [Abstract][Full Text] [Related]
8. Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms. Yang Z; Liu Y; Song Z; Fan Y; Lin S; Ge Z; Feng S; Liu Y; Bi Y; Wang Y; Wang X; Mao J Int J Med Sci; 2023; 20(8):1024-1037. PubMed ID: 37484810 [TBL] [Abstract][Full Text] [Related]
9. [Disease-syndrome combination in integrated traditional Chinese and Western medicine in andrology: Confusions and countermeasures in studies]. Zhang MJ Zhonghua Nan Ke Xue; 2017 Jul; 23(7):579-582. PubMed ID: 29723448 [TBL] [Abstract][Full Text] [Related]
10. Methodology of pharmacodynamic evaluation on Chinese herbal medicine based on syndrome differentiation. Lu AP; Liu XW; Ding XR Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):501-4. PubMed ID: 19583928 [TBL] [Abstract][Full Text] [Related]
11. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. Chan K; Shaw D; Simmonds MS; Leon CJ; Xu Q; Lu A; Sutherland I; Ignatova S; Zhu YP; Verpoorte R; Williamson EM; Duez P J Ethnopharmacol; 2012 Apr; 140(3):469-75. PubMed ID: 22330011 [TBL] [Abstract][Full Text] [Related]
12. [Research and application of hepatotoxicity evaluation technique of traditional Chinese medicine]. Song J; Zhong RL; Xia Z; Wu H; Zhong QX; Zhang ZH; Wei YJ; Shi ZQ; Feng L; Jia XB Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(1):41-48. PubMed ID: 28945023 [TBL] [Abstract][Full Text] [Related]
13. [Research and development of new traditional Chinese medicine drugs for certain syndromes based on "theoretical innovation"]. Lian MA; Ke-Bin W; Sheng-Xian WU Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):5048-5056. PubMed ID: 33350282 [TBL] [Abstract][Full Text] [Related]
14. [Difficulties and countermeasures in research for prevention and treatment of coronary heart disease by integrative Chinese and Western medicine]. Xu H; Chen KJ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jul; 27(7):647-9. PubMed ID: 17717931 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of cardiovascular disease with Xiongshao capsule]. Yuan R; Wang Y; Cong WH; Chen KJ Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(4):640-643. PubMed ID: 28959830 [TBL] [Abstract][Full Text] [Related]
16. [Thinking of current situation of animal model of tradition Chinese medicine combining disease and syndrome]. Chai C; Kou J; Zhu D; Yan Y; Yu B Zhongguo Zhong Yao Za Zhi; 2009 Oct; 34(20):2673-5. PubMed ID: 20069913 [TBL] [Abstract][Full Text] [Related]
17. Traditional Chinese Medicine and heart disease: what does Western medicine and nursing science know about it? Davidson P; Hancock K; Leung D; Ang E; Chang E; Thompson DR; Daly J Eur J Cardiovasc Nurs; 2003 Sep; 2(3):171-81. PubMed ID: 14622624 [TBL] [Abstract][Full Text] [Related]
18. [Turbid-phlegm is an important pathogenesis of restenosis after percutaneous transluminal coronary intervention]. Wang DY; Jin HG Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):750-3. PubMed ID: 16152841 [TBL] [Abstract][Full Text] [Related]
19. [Perspective and application of metabonomics in modern study of traditional Chinese medicine]. Qin KM; Wang B; Chen LW; Zhang MS; Yang GM; Shu YC; Cai BC Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3010-7. PubMed ID: 25509279 [TBL] [Abstract][Full Text] [Related]
20. [A perspective of developing syndrome diagnostic criteria based on syndrome factors and combination of disease in modern medicine system and syndrome in traditional Chinese medicine system]. Wang TF; DU CF; Wang QG; Wu XY; Wang ZY; Zhao Y; Xue XL; Deng HL; Yue H; Yu LL; Qu K; Yu CG; Xu WJ Zhong Xi Yi Jie He Xue Bao; 2009 Oct; 7(10):901-6. PubMed ID: 19828099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]